10-K

Company

KalVista Pharmaceuticals, Inc.

Filed

July 7, 2022

Period of Report

April 30, 2022

Accession Number

0000950170-22-012521

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →